Foghorn Therapeutics Inc.
FHTX | NASDAQ
$4.26
+$0.11 (+2.65%)
Sep 22, 2026, 12:17 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -4.58 | -2.99 | -2.76 | -2.44 | -8.23 | -10.67 |
PEG Ratio | 0.18 | 0.09 | 0.26 | 0.42 | -0.18 | -0.30 |
PS Ratio | 11 | 11.46 | 7.93 | 13.80 | 644.51 | 1.73K |
PB Ratio | -3.13 | -5.69 | -3.51 | 2.37K | 8.78 | 5.10 |
P/FCF Ratio | -3.95 | -2.56 | -2.27 | 1.38 | -15.87 | -15.71 |
P/OCF Ratio | -3.95 | -2.58 | -2.29 | 1.37 | -16.92 | -23.84 |
OCF/S Ratio | -278.56 | -444.24 | -345.79 | 1.01K | -3.81K | -7.28K |
Debt / Equity Ratio | -0.38 | -0.82 | -0.58 | 459.88 | 0.60 | 0.56 |
Quick Ratio | 2.73 | 3.73 | 4.11 | 6.37 | 9.44 | 10.12 |
Current Ratio | 2.73 | 3.73 | 4.11 | 6.37 | 9.44 | 10.12 |
Asset Turnover | 0.16 | 0.08 | 0.12 | 0.05 | 0 | 0 |
Interest Coverage | n/a | n/a | n/a | n/a | -52.85 | -70 |
Return on Equity | 68.46% | 190.26% | 127.51% | -97.22K% | -104.59% | -47.06% |
Return on Assets | -37.50% | -30.50% | -34.42% | -26.89% | -19.49% | -26.92% |
Return on Invested Capital | -58.95% | -45.42% | -45.72% | -32.94% | -21.07% | -28.47% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 89.22% | 100% | 100% | 100% | 100% | -13.32K% |
Net Profit Margin | -240.33% | -383.24% | -288.17% | -566.27% | -7.68K% | -16K% |
Pretax Profit Margin | -240.33% | -383.24% | -275.80% | -566.27% | -7.68K% | -16K% |
Operating Profit Margin | -265.64% | -454.31% | -315.93% | -609.20% | -7.64K% | -15.94K% |
FCF Margin | -278.72% | -448.24% | -349.38% | 1K% | -4.06K% | -11.04K% |
EBITDA Margin | -229.55% | -429.90% | -265.70% | -549% | -7.29K% | -15.63K% |
Add to Watchlist
Select watchlists to add or remove FHTX